LG CNS Showcases AX Solution for Pharmaceutical Manufacturing at CPHI Milan

LG CNS is taking part in CPHI Milan 2026, a significant event for the pharmaceutical and biotechnology industries, to showcase its AX solution developed for the sector. This participation aims to broaden AX's reach within the global pharmaceutical market.

The LG CNS AX solution offers specific functionalities to optimize key pharmaceutical manufacturing processes. Demonstrations will focus on plant design, production operations, and quality management, centered around the theme 'The Autonomous Factory in the Pharmaceutical Sector'.

CPHI Milan 2026 brings together global players in pharmaceuticals and biotechnology. LG CNS seeks to position AX as a crucial tool for the digital transformation of companies in the sector, emphasizing automation and artificial intelligence to enhance efficiency and regulatory compliance.

The company anticipates that its presence at this event will facilitate new partnerships and strengthen its market position for technologies serving the pharmaceutical industry. The AX solution is designed to support companies in their transition towards smarter, more connected production environments.